Table 1 Clinical and metabolic features of the studied population

From: Lack of awareness of liver organ damage in patients with type 2 diabetes

Characteristic Entire population (n = 825)
Male participants (%) 52.9 ± 3.26
Age (years) 60.6 ± 1.05
Diabetes duration (years) 10.1 ± 1.03
BMI (Kg/m2) 33.3 ± 0.53
Obesity (%) 64.1 ± 2.96
Waist circumference (cm) 111.9 ± 1.05
Current smoke (%) 27.0 ± 4.02
Ethnicity (%)
 Non-Hispanic white 56.9 ± 3.30
 Non-Hispanic black 13.3 ± 2.44
 Hispanics 16.1 ± 1.94
 Asian 7.5 ± 1.24
 Others 6.2 ± 1.10
Hepatitis B (%) 1.00 ± 0.03
Hepatitis C (%) 0.4 ± 0.21
Laboratory features
 HbA1c (%, mmol/mol) 7.2, 55.2 ± 0.46
 AST (U/l) 22.2 ± 0.57
 ALT (U/l) 24.8 ± 0.91
 GGT (U/l) 36.9 ± 1.99
 Platelet count (× 109/L) 241.9 ± 5.44
 Albumin (g/l) 39 ± 0.2
 Total Cholesterol (mmol/l) 4.7 ± 0.07
 HDL-cholesterol (mmol/l) 1.2 ± 0.02
 Triglycerides (mmol/l) 2.3 ± 0.13
 LDL-cholesterol (mmol/l) 2.4 ± 0.06
  1. Data are expressed as weighted proportions (± Standard Error (SE)) for categorical variables and as weighted means ± SE for continuous variables
  2. BMI Body mass index; HbA1c, Hemoglobin A1c; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; GGT, Gamma-glutamyltranspeptidase; HDL, High density lipoprotein; LDL, Low density lipoprotein